Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Tandem Diabetes Care (TNDM) Other Operating Expenses (2017 - 2025)

Historic Other Operating Expenses for Tandem Diabetes Care (TNDM) over the last 8 years, with Q1 2025 value amounting to $75.2 million.

  • Tandem Diabetes Care's Other Operating Expenses changed N/A to $75.2 million in Q1 2025 from the same period last year, while for Sep 2025 it was $75.2 million, marking a year-over-year change of. This contributed to the annual value of $78.8 million for FY2023, which is 15371.31% up from last year.
  • Per Tandem Diabetes Care's latest filing, its Other Operating Expenses stood at $75.2 million for Q1 2025.
  • Tandem Diabetes Care's Other Operating Expenses' 5-year high stood at $78.8 million during Q1 2023, with a 5-year trough of -$1000.0 in Q4 2024.
  • In the last 4 years, Tandem Diabetes Care's Other Operating Expenses had a median value of $31.0 million in 2022 and averaged $37.0 million.